Surface translocation and tri-iodothyronine uptake of mutant MCT8 proteins are cell type-dependent

Journal of Molecular Endocrinology

Volumn 43, Issue 6, 2009, Pages 263-271

  Kinne, Anita ^a   Roth, Stephan ^a   Biebermann, Heike ^a   Köhrle, Josef ^a   Grüters, Annette ^a   Schweizer, Ulrich ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ASPARTIC ACID; CHAPERONE; GLYCINE; HISTIDINE; LEUCINE; LIOTHYRONINE; MESSENGER RNA; MONOCARBOXYLATE TRANSPORTER 8; PROLINE;

ARTICLE; BIOCHEMICAL COMPOSITION; BIOTINYLATION; CELL LINE; CELL STRAIN; CELL SURFACE; CELL TYPE; CONTROLLED STUDY; DOG; GENE EXPRESSION; GENE TRANSLOCATION; HORMONE TRANSPORT; HUMAN; HUMAN CELL; JEG1 CELL; KINETICS; MDCK1 CELL; MENTAL DEFICIENCY; MISSENSE MUTATION; MOUSE; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN VARIANT;

ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL LINE; DOGS; HELA CELLS; HUMANS; MONOCARBOXYLIC ACID TRANSPORTERS; MUTATION, MISSENSE; TRIIODOTHYRONINE;

EID: 71649109028     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1677/JME-09-0043     Document Type: Article

References (32)

1. Bernier V, Lagace M, Bichet DG & Bouvier M 2004 Pharmacological chaperones: potential treatment for conformational diseases. Trends in Endocrinology and Metabolism 15 222-228. (Pubitemid 38833993)
2. Biebermann H, Ambrugger P, Tarnow P, von Moers A, Schweizer U & Grueters A 2005 Extended clinical phenotype, endocrine investigations and functional studies of a loss-of-function mutation A150V in the thyroid hormone specific transporter MCT8. European Journal of Endocrinology 153 359-366. (Pubitemid 41410491)
3. Burrows JA, Willis LK & Perlmutter DH 2000 Chemical chaperones mediate increased secretion of mutant alpha 1-antitrypsin (alpha 1-AT) Z: a potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency. PNAS 97 1796-1801.
4. Dumitrescu AM, Liao XH, Best TB, Brockmann K & Refetoff S 2004 A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. American Journal of Human Genetics 74 168-175. (Pubitemid 38085248)
5. Dumitrescu AM, Liao XH, Weiss RE, Millen K & Refetoff S 2006 Tissue-specific thyroid hormone deprivation and excess in monocarboxylate transporter (mct) 8-deficient mice. Endocrinology 147 4036-4043. (Pubitemid 44268357)
6. Friesema EC, Ganguly S, Abdalla A, Manning Fox JE, Halestrap AP & Visser TJ 2003 Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. Journal of Biological Chemistry 278 40128-40135. (Pubitemid 37248580)
7. Friesema EC, Grueters A, Biebermann H, Krude H, von Moers A, Reeser M, Barrett TG, Mancilla EE, Svensson J, Kester MH et al. 2004 Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation. Lancet 364 1435-1437. (Pubitemid 39370719)
8. 3 levels caused by mutations in monocarboxylate transporter 8. Nature Clinical Practice. Endocrinology and Metabolism 2 512-523.
9. Friesema ECH, Jansen J, Jachtenberg JW, Visser WE, Kester MH & Visser TJ 2008 Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10. Molecular Endocrinology 22 1357-1369. (Pubitemid 351786996)
10. Frints SG, Lenzner S, Bauters M, Jensen LR, Van Esch H, des Portes V, Moog U, Macville MV, van Roozendaal K, Schrander-Stumpel CT et al. 2008 MCT8 mutation analysis and identification of the first female with Allan-Herndon-Dudley syndrome due to loss of MCT8 expression. European Journal of Human Genetics 16 1029-1037.
11. Grüters A, Biebermann H & Krude H 2003 Neonatal thyroid disorders. Hormone Research 59 24-29.
12. Halestrap AP & Meredith D 2004 The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond. Pflügers Archiv 447 619-628. (Pubitemid 38241446)
13. von Heijne G 2006 Membrane-protein topology. Nature Reviews. Molecular Cell Biology 7 909-918.
14. Hennemann G, Docter R, Friesema EC, de Jong M, Krenning EP & Visser TJ 2001 Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability. Endocrine Reviews 22 451-476. (Pubitemid 32762323)
15. Herzovich V, Vaiani E, Marino R, Dratler G, Lazzati JM, Tilitzky S, Ramirez P, Iorcansky S, Rivarola MA & Belgorosky A 2007 Unexpected peripheral markers of thyroid function in a patient with a novel mutation of the MCT8 thyroid hormone transporter gene. Hormone Research 67 1-6. (Pubitemid 46257001)
16. Heuer H, Maier MK, Iden S, Mittag J, Friesema EC, Visser TJ & Bauer K 2005 The monocarboxylate transporter 8 linked to human psychomotor retardation is highly expressed in thyroid hormone-sensitive neuron populations. Endocrinology 146 1701-1706. (Pubitemid 40396877)
17. Holden KR, Zuniga OF, May MM, Su H, Molinero MR, Rogers RC & Schwartz CE 2005 X-linked MCT8 gene mutations: characterization of the pediatric neurologic phenotype. Journal of Child Neurology 20 852-857. (Pubitemid 43124480)
18. James SR, Franklyn JA, Reaves BJ, Smith VE, Chan SY, Barrett TG, Kilby MD & McCabe CJ 2008 Monocarboxylate transporter 8 (MCT8) in neuronal cell growth. Endocrinology 150 1961-1969.
19. Jansen J, Friesema EC, Milici C & Visser TJ 2005 Thyroid hormone transporters in health and disease. Thyroid 15 757-768.
20. Jansen J, Friesema EC, Kester MH, Milici C, Reeser M, Gruters A, Barrett TG, Mancilla EE, Svensson J, Wemeau JL et al. 2007 Functional analysis of monocarboxylate transporter 8 mutations identified in patients with X-linked psychomotor retardation and elevated serum triiodothyronine. Journal of Clinical Endocrinology and Metabolism 92 2378-2381.
21. Jansen J, Friesema EC, Kester MH, Schwartz CE & Visser TJ 2008 Genotype-phenotype relationship in patients with mutations in thyroid hormone transporter MCT8. Endocrinology 149 2184-2190. (Pubitemid 351574539)
22. Kakinuma H, Itoh M & Takahashi H 2005 A novel mutation in the monocarboxylate transporter 8 gene in a boy with putamen lesions and low free T4 levels in cerebrospinal fluid. Journal of Pediatrics 147 552-554. (Pubitemid 41446556)
23. Kleizen B & Braakman I 2004 Protein folding and quality control in the endoplasmic reticulum. Current Opinion in Cell Biology 16 343-349. (Pubitemid 38903139)
24. Maranduba CM, Friesema EC, Kok F, Kester MH, Jansen J, Sertie AL, Passos-Bueno MR & Visser TJ 2006 Decreased cellular uptake and metabolism in Allan-Herndon-Dudley syndrome (AHDS) due to a novel mutation in the MCT8 thyroid hormone transporter. Journal of Medical Genetics 43 457-460.
25. Morte B, Manzano J, Scanlan T, Vennstrom B & Bernal J 2002 Deletion of the thyroid hormone receptor alpha 1 prevents the structural alterations of the cerebellum induced by hypothyroidism. PNAS 99 3985-3989. (Pubitemid 34252217)
26. Schulz A, Sangkuhl K, Lennert T, Wigger M, Price DA, Nuuja A, Gruters A, Schultz G & Schoneberg T 2002 Aminoglycoside pretreatment partially restores the function of truncated V(2) vasopressin receptors found in patients with nephrogenic diabetes insipidus. Journal of Clinical Endocrinology and Metabolism 87 5247-5257. (Pubitemid 35316371)
27. Schwartz CE, May MM, Carpenter NJ, Rogers RC, Martin J, Bialer MG, Ward J, Sanabria J, Marsa S, Lewis JA et al. 2005 Allan-Herndon-Dudley syndrome and the monocarboxylate transporter 8 (MCT8) gene. American Journal of Human Genetics 77 41-53. (Pubitemid 40848035)
28. Trajkovic M, Visser TJ, Mittag J, Horn S, Lukas J, Darras VM, Raivich G, Bauer K & Heuer H 2007 Abnormal thyroid hormone metabolism in mice lacking the monocarboxylate transporter 8. Journal of Clinical Investigation 117 627-635. (Pubitemid 46348521)
29. Visser WE, Friesema EC, Jansen J & Visser TJ 2007 Thyroid hormone transport by monocarboxylate transporters. Best Practice and Research. Clinical Endocrinology and Metabolism 21 223-236. (Pubitemid 46888199)
30. Wemeau JL, Pigeyre M, Proust-Lemoine E, d'Herbomez M, Gottrand F, Jansen J, Visser TJ & Ladsous M 2008 Beneficial effects of propylthiouracil plus L-thyroxine treatment in a patient with a mutation in MCT8. Journal of Clinical Endocrinology and Metabolism 93 2084-2088.
31. Wirth EK, Roth S, Blechschmidt C, Hölter SH, Becker L, Racz I, Zimmer A, Klopstock T, Gailus-Durner V, Fuchs H et al. 2009 Neuronal T3 uptake and behavioral phenotype of mice deficient in Mct8, the neuronal T3 transporter mutated in Allan-Herndon-Dudley syndrome. Journal of Neuroscience 29 9439-9449.
32. Zoeller TR, Dowling AL, Herzig CT, Iannacone EA, Gauger KJ & Bansal R 2002 Thyroid hormone, brain development, and the environment. Environmental Health Perspectives 110 355-361. (Pubitemid 34661941)